Navigation Links
CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study
Date:10/25/2007

h a target enrollment of 120 subjects.

Len Brandt, CEO of CNS Response, commented, "The original design of our Treatment-Resistant Depression Study developed from conversations with scientific and academic advisors, but there really was not a model for such a study. Following our quality assurance assessment, we reached the conclusion that the methodology was not as practical to implement as hoped. As a result, we are modifying the trial design in order to enhance its overall functionality and ensure the integrity of the results.

"This process will delay our ability to complete the multi-site study as originally projected. We expect, however, that the new trial design will ultimately improve the speed by which patients can be tested and treated. The new design will also allow us to introduce an additional arm involving patients with a different depression indication. We expect that the re-design will eliminate the need for a previously-contemplated second study and will now allow us to generate a robust set of results earlier than previously estimated. Together these two studies, along with the prior-reported successful pilot study, should provide CNS Response with a strong set of results showing the efficacy of rEEGSM in guiding patients who failed initial depressive treatment.

"The three key changes that we are making to the trial design involve un- blinding the treatment physicians, using the STAR*D treatment algorithm instead of TMAP, and adjusting certain trial subject qualifications.

"The need to blind the treatment physicians was a product of the original trial design which called for the patients, treating physicians, raters and rEEGSM technicians to be blind to which patients were in each arm of the study. This arrangement proved difficult to implement because many of the site's treating physicians felt the ethical need to understand the basis of treatment with selected medications in order to better dose and monitor the patients. Fu
'/>"/>

SOURCE CNS Response, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Man against HIV – new vaccine ready for human trials
2. FDA approves Phase 0 trial which tests experimental drugs on humans
3. Male contraceptive in trial
4. How do patients benefit of clinical trials
5. Glenmark’s new molecule to go through trial
6. Clinical trials need to be more frank
7. First head-to-head trials of once weekly Fosamax and Actonel therapies
8. Hormone Replacement Therapy increases the risk of endometrial cancer
9. Atrial fibrillation predicts for acute ischaemic stroke
10. Spray on contraceptive clears Phase I trial
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Delta, a reliable supplier of high quality ... D7R Dozers to its used bulldozer collection. ... that all these items are offered with deep discounts. ... Delta’s market share in the coming September. , ... offer; he has much confidence in the discounted Used ...
(Date:8/27/2014)... Philadelphia, PA. Inc. magazine ranked Holganix as No. ... exclusive ranking of the nation’s fastest-growing privately held companies. ... most important segment of the economy - America’s independent ... members of the Inc. 500 list include Dell, LinkedIn, ... world’s greatest companies have had their start on the ...
(Date:8/27/2014)... Diego, CA (PRWEB) August 27, 2014 ... insurance policies will now be easier for the public ... insurance prices that are promoted in all 50 states ... . , The different insurers that are generating ... made it possible for adults to use the programmed ...
(Date:8/27/2014)... August 27, 2014 Today, Zane Benefits, ... on compliance tips for administering a premium reimbursement plan. ... in full effect, compliance is top of mind for ... to individual health insurance and premium reimbursement, there are ... In the 35 minute webinar, Zane Benefits President, Rick ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Top 10 Best ... compared many Linux hosting suppliers and announced iPage, Bluehost and ... USA, UK, Canada, Australia and Europe to buy useful hosting ... the most reliable suppliers, iPage has been serving ... years’ development, it has grown into a leader in the ...
Breaking Medicine News(10 mins):Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Inc Magazine Unveils 33rd Annual List of America's Fastest-Growing Private Companies - the Inc. 500 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Well-known SEO Hosts Review Site Top10BestSEOHosting.com Recommends iPage, Bluehost and GoDaddy To Webmasters 2
... topical compound is as effective at treating the skin ... the standard therapy, a less-available, costlier compound injected into ... team from Johns Hopkins University , Harvard ... by Reza F. Ghohestani, M.D., Ph.D., director of the ...
... Receives EU and US Approvals for Intravenous Formulation of ... Sachet PresentationKENILWORTH, N.J., March 5 Schering-Plough Corporation (NYSE: ... Commission and the US FDA both approved the intravenous ... already approved oral form of the drug. Temozolomide ...
... to ExpertsBETHESDA, Md., March 5 The American College of ... the March issue of The American Journal of Gastroenterology. ... update of those published by ACG in 2000. Key ... , ...
... acquisition of NMHC drives GAAP earnings per share growth, ... up from $6.5 million in Q4, ... Corp. ("SXC" or the "Company") (NASDAQ: SXCI , TSX: ... ended December 31, 2008. Financial references are in U.S. dollars unless ...
... Anti-Doping Agency (WADA) has banned athletes from using bottled ... of the sports that it governs.LAKE FOREST, Calif., March ... Anti-Doping Agency (WADA), bottled or canned oxygen is banned ... "Artificially enhancing the uptake, transport or delivery of oxygen ...
... imaging and file conversion services available through Lifeboat,s reseller network; ... , ... Northglenn, CO (PRWEB) March ... the imaging industry, today announced a distribution agreement with Lifeboat ...
Cached Medicine News:Health News:The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection 2Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 2Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 3Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 4Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 5Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 6Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 7Health News:American College of Gastroenterology Issues Updated Colorectal Cancer Guidelines 2Health News:American College of Gastroenterology Issues Updated Colorectal Cancer Guidelines 3Health News:American College of Gastroenterology Issues Updated Colorectal Cancer Guidelines 4Health News:SXC Health solutions announces strong fourth quarter and year end financial results 2Health News:SXC Health solutions announces strong fourth quarter and year end financial results 3Health News:SXC Health solutions announces strong fourth quarter and year end financial results 4Health News:SXC Health solutions announces strong fourth quarter and year end financial results 5Health News:SXC Health solutions announces strong fourth quarter and year end financial results 6Health News:SXC Health solutions announces strong fourth quarter and year end financial results 7Health News:SXC Health solutions announces strong fourth quarter and year end financial results 8Health News:SXC Health solutions announces strong fourth quarter and year end financial results 9Health News:SXC Health solutions announces strong fourth quarter and year end financial results 10Health News:SXC Health solutions announces strong fourth quarter and year end financial results 11Health News:SXC Health solutions announces strong fourth quarter and year end financial results 12Health News:SXC Health solutions announces strong fourth quarter and year end financial results 13Health News:SXC Health solutions announces strong fourth quarter and year end financial results 14Health News:SXC Health solutions announces strong fourth quarter and year end financial results 15Health News:SXC Health solutions announces strong fourth quarter and year end financial results 16Health News:SXC Health solutions announces strong fourth quarter and year end financial results 17Health News:SXC Health solutions announces strong fourth quarter and year end financial results 18Health News:SXC Health solutions announces strong fourth quarter and year end financial results 19Health News:SXC Health solutions announces strong fourth quarter and year end financial results 20Health News:Oxygen4Energy: International Sports News - World Anti-Doping Agency (WADA) Bans Oxygen Use 2Health News:Lifeboat Distribution and ImageDoc USA Sign Distribution Agreement 2
(Date:8/27/2014)... 27, 2014 Reportbuyer.com has added ... Co-development Terms & Agreements in Pharma, Biotech ... The Co-development Terms and Agreements ... comprehensive understanding and unprecedented access to the ... the worlds leading life science companies. ...
(Date:8/27/2014)... and MENLO PARK, Calif. , Aug. ... DMPI), developer of advanced cancer therapeutics , will ... Annual Rodman & Renshaw Global Investment Conference, sponsored by ... take place Tuesday, September 9th at 2:55 p.m. EDT ... New York Palace Hotel in New York ...
(Date:8/27/2014)... , Aug. 27, 2014 Research ... "Global Pulse Oximeter Industry Report 2014" report to ... Industry Report 2014 is a professional and in-depth study ... industry. The report provides a basic overview ... chain structure. The pulse oximeter market analysis is provided ...
Breaking Medicine Technology:Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 2Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 3Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 4Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 5Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 6Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 7DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Global Pulse Oximeter Industry Report 2014 2
... PITTSBURGH, Nov. 10, 2011 Building on the success ... Positive Airway Pressure) mask, Circadiance is proud to introduce ... users will hardly know it,s there. Used ... Feather Weight Tube from Circadiance complements the CPAP mask ...
... VILLAGE, Colo., Nov. 10, 2011 Ampio Pharmaceuticals, ... the "Company"), a company that discovers and develops ... molecular entities ("NMEs"), today announced that an IRB ... for Allergy and Asthma in Denver, Colorado indicates ...
Cached Medicine Technology:Circadiance Launches Revolutionary New CPAP Tube 2Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation 2Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation 3
Microplate incubator shaker used in a variety of immunoassay and research procedures requiring microplates....
... especially suited for cell analysis and ... allows to analyze scatter signals in ... channels. Data acquisition, analysis, and real-time ... PC employing Partec DPAC software, built-in ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
... The IMMULITE 1000 immunoassay system ... use, reliability, robust hardware and excellent ... onboard reagents and accommodates onboard dilutions, ... , , Worldwide, IMMULITE 1000 (and ...
Medicine Products: